Y Intercept (Hong Kong) LTD Novo Cure LTD Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Novo Cure LTD stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 21,727 shares of NVCR stock, worth $248,339. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,727
Previous 23,492
7.51%
Holding current value
$248,339
Previous $418,000
7.66%
% of portfolio
0.01%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding NVCR
# of Institutions
261Shares Held
79MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$139 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$129 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$102 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$63.1 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$59.6 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.2B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...